dokter_no · 7 years ago
Dr de Santis draws an important conclusion: it’s time to include patient reported outcome measures in #ProstateCancer trials. #eau18
Morning #EAU18 ! Managed to find a table covered in sweets from @UromedTech which is a lovely start to Sunday. Although not helping me cover the big news in #urology for @EMJUrology https://t.co/Wk4TeYbBNs
Maria DeSantis citing @urotoday from the podium at #EAU18 https://t.co/cFrImMZkYp
Another beautiful cold day at #eau18 #Copenhagen. https://t.co/KSRjSmtdYw
Prostate MRI course #EAU18 day 3 ✌?
Cc: @mczarnieckiMD https://t.co/Q2heqeQPkN
Would you treat the primary surgically in ‘oligometastatic’ prostate cancer? Excellent presentation by @joniau arguing this case.
#EAU18 https://t.co/5s3lTwOgcW
Demo room already in action at #EAU18, as attendees experience the patent protected MOSES Technology – providing more efficiency and better control in stones and BPH treatments. Visit the Lumenis booth G16. https://t.co/aVw8ax9Md0
#EAU18 N. Motter cautions “look before you leap” – evidence for cM0 but PSMA-based M1 treatment is not there yet! https://t.co/qneJ2iODg0
New study in @EUPlatinum suggests that the growth factor receptor bound protein 10 gene may be used as a new molecular target to enhance current castration-resistant #prostatecancer therapy: https://t.co/dhjMjs6nYH #EAU18 https://t.co/pLxpYQgrAp
We look forward to presenting innovations and highlights in our booth. Come by to have a coffee with us – join @WellspectHC at #EAU18 https://t.co/DWpT9CtJyJ https://t.co/RBlvuFf9Py
Good discussion on oligometastatic prostate cancer #EAU18 https://t.co/dLQJCC3sl9
Love this. Great example of being #different at #eau18 in order to stand out and ensure the message is remembered. Great work! https://t.co/N3cE0w2ycQ